Clinical Trial Update: PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease [Phase 1]

View source ↗

Summary

Phase 1 imaging study update from GlaxoSmithKline evaluating PBMC/Lymphocyte SPECT imaging in Crohn's disease. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED